Sekiya Ichiro, Muneta Takeshi, Koga Hideyuki, Nimura Akimoto, Morito Toshiyuki, Shimaya Masayuki, Mochizuki Tomoyuki, Segawa Yuko, Sakaguchi Yusuke, Tsuji Kunikazu, Ichinose Shizuko
Section of Cartilage Regeneration, Tokyo Medical and Dental University, Tokyo, Japan.
Clin Calcium. 2011 Jun;21(6):879-89.
Cell transplantation has shown to be a promising strategy to repair cartilage defects. Mesenchymal stem cells derived from synovium have been shown to be a superior cell source for cartilage regeneration to those from other mesenchymal tissues due to their higher rates of colony formation, proliferation potential with autologous serum, and in vitro/vivo chondrogenic potentials. We have found that approximately 60% of synovial mesenchymal stem cells placed on cartilage defects adhered to the defect within 10 min, and the addition of magnesium enhanced this percentage further, which resulted in better cartilage regeneration. Based upon several basic research studies performed in our lab, we have begun the transplantation of synovial stem cells arthroscopically in a clinical study for the treatment of cartilage defects. To date, no adverse events have been reported in the study. Regeneration of cartilage, reduction in defect size and an improvement of symptoms have been obtained in most patients over the last 3 years.
细胞移植已被证明是修复软骨缺损的一种有前景的策略。源自滑膜的间充质干细胞已被证明是软骨再生的优质细胞来源,优于其他间充质组织来源的细胞,这是因为它们具有更高的集落形成率、在自体血清中的增殖潜力以及体内外软骨形成潜力。我们发现,置于软骨缺损处的滑膜间充质干细胞约60%在10分钟内粘附于缺损处,而添加镁进一步提高了这一比例,从而带来更好的软骨再生效果。基于我们实验室开展的多项基础研究,我们已开始在一项治疗软骨缺损的临床研究中通过关节镜进行滑膜干细胞移植。迄今为止,该研究中尚未报告不良事件。在过去3年里,大多数患者实现了软骨再生、缺损尺寸减小以及症状改善。